%0 Journal Article
%T Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems.
%A Akturk HK
%A Battelino T
%A Castañeda J
%A Arrieta A
%A van den Heuvel T
%A Cohen O
%J Diabetes Technol Ther
%V 26
%N 0
%D 2024 Mar
%M 38377325
%F 7.337
%R 10.1089/dia.2023.0432
%X The concept of maintaining blood glucose levels within the 70-180 mg/dL range, known as time-in-range, has raised questions regarding its representation of true physiological euglycemia. Some have speculated that focusing on the time spent within the 70-140 mg/dL range, introduced as time in tight range (TITR) through the International Consensus statement, could serve as a more precise metric for assessing normoglycemia in individuals with type 1 diabetes. This article delves into the current status of TITR as an emerging marker and explores how advanced hybrid closed-loop systems may offer a promising avenue for achieving this higher level of glycemic control.